Skip to main content

News

New Clinical Guidance for the Management of Lobular Carcinoma In situ

Cancer Australia has released new clinical guidance to assist health professionals in the management of women diagnosed with lobular carcinoma in situ (LCIS).

LCIS is a growth of abnormal cells in the lobules of the breast. LCIS is not invasive breast cancer, but women who have LCIS have a high risk of developing breast cancer later in life. LCIS is a rare condition, and is found in approximately 0.4–3.8% of women who have had a breast biopsy.

The new Clinical guidance for the management of lobular carcinoma in situ, developed with the assistance of a multidisciplinary working group, aims to address the wide variation in how LCIS is managed in Australia.

View the Clinical guidance for the management of lobular carcinoma in situ.